215 related articles for article (PubMed ID: 32361007)
21. FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.
Mapelli P; Broggi S; Incerti E; Alongi P; Kirienko M; Fiorino C; Dell Oca I; Fallanca F; Vanoli EG; Di Muzio NG; Gianolli L; Picchio M
Curr Radiopharm; 2017 Aug; 10(2):102-110. PubMed ID: 28412923
[TBL] [Abstract][Full Text] [Related]
22. Adaptive dose painting by numbers for head-and-neck cancer.
Duprez F; De Neve W; De Gersem W; Coghe M; Madani I
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1045-55. PubMed ID: 20643512
[TBL] [Abstract][Full Text] [Related]
23. Tumor Voxel Dose-Response Matrix and Dose Prescription Function Derived Using
Yan D; Chen S; Krauss DJ; Chen PY; Chinnaiyan P; Wilson GD
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):207-218. PubMed ID: 30684661
[TBL] [Abstract][Full Text] [Related]
24. Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.
Lee N; Nehmeh S; Schöder H; Fury M; Chan K; Ling CC; Humm J
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):101-8. PubMed ID: 19203843
[TBL] [Abstract][Full Text] [Related]
25. Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc.
Differding S; Sterpin E; Hermand N; Vanstraelen B; Nuyts S; de Patoul N; Denis JM; Lee JA; Grégoire V
Radiat Oncol; 2017 Mar; 12(1):59. PubMed ID: 28335778
[TBL] [Abstract][Full Text] [Related]
26. Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for ¹⁸F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study.
Teoh M; Beveridge S; Wood K; Whitaker S; Adams E; Rickard D; Jordan T; Nisbet A; Clark CH
Med Dosim; 2013; 38(1):18-24. PubMed ID: 22841937
[TBL] [Abstract][Full Text] [Related]
27. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of
Berwouts D; Madani I; Duprez F; Olteanu AL; Vercauteren T; Boterberg T; Deron P; Bonte K; Huvenne W; De Neve W; Goethals I
Head Neck; 2017 Nov; 39(11):2264-2275. PubMed ID: 28833829
[TBL] [Abstract][Full Text] [Related]
29. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
[TBL] [Abstract][Full Text] [Related]
30. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
[TBL] [Abstract][Full Text] [Related]
31. Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer.
Sher DJ; Pham NL; Shah JL; Sen N; Williams KA; Subramaniam RM; Moore W; Chorley R; Ahn C; Khan SM
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):932-940. PubMed ID: 33127491
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
33. Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial.
Berwouts D; Olteanu LA; Duprez F; Vercauteren T; De Gersem W; De Neve W; Van de Wiele C; Madani I
Radiother Oncol; 2013 Jun; 107(3):310-6. PubMed ID: 23647760
[TBL] [Abstract][Full Text] [Related]
34. Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
Sanli Y; Zukotynski K; Mittra E; Chen DL; Nadel H; Niederkohr RD; Subramaniam RM
Clin Nucl Med; 2018 Dec; 43(12):e439-e452. PubMed ID: 30394934
[TBL] [Abstract][Full Text] [Related]
35. Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.
Truong MT; Romesser PB; Qureshi MM; Kovalchuk N; Orlina L; Willins J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):158-64. PubMed ID: 22300574
[TBL] [Abstract][Full Text] [Related]
36. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
37. Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer.
Yap ML; Sun A; Higgins J; Clarke K; Marshall A; Becker N; Le LW; Vines DC; Bezjak A; Bissonnette JP
Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e199-e205. PubMed ID: 27637725
[TBL] [Abstract][Full Text] [Related]
38. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.
Schwartz DL; Garden AS; Thomas J; Chen Y; Zhang Y; Lewin J; Chambers MS; Dong L
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):986-93. PubMed ID: 22138459
[TBL] [Abstract][Full Text] [Related]
39. Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort.
Zhong J; Sundersingh M; Dyker K; Currie S; Vaidyanathan S; Prestwich R; Scarsbrook A
Sci Rep; 2020 Mar; 10(1):4086. PubMed ID: 32139722
[TBL] [Abstract][Full Text] [Related]
40. Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
Mohamed ASR; Cardenas CE; Garden AS; Awan MJ; Rock CD; Westergaard SA; Brandon Gunn G; Belal AM; El-Gowily AG; Lai SY; Rosenthal DI; Fuller CD; Aristophanous M
Radiother Oncol; 2017 Aug; 124(2):248-255. PubMed ID: 28774596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
